2021 ASCO Virtual Direct™ Highlights

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

2021 ASCO Virtual Direct™ Highlights

St. Louis
Jacksonville
Denver
Philadelphia
San Francisco

Playback speed

10 seconds

2021 ASCO Key Takeaways From Non-prostate Cancer Studies: Adjuvant Therapy for RCC, 1L Therapy for mRCC, IO/TKI in nccRCC

By 2021 ASCO Virtual Direct™ Highlights FEATURING Pooja Ghatalia

24 views

August 20, 2021

Comments 0

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Philadelphia

ASCO 2021 Q&A Discussion on GI Cancers: New Findings and Data Overvi…

2021 ASCO Virtual Direct™ Highlights

D. Lin, A. Loaiza-Bonilla

623 views

2021 ASCO Highlights on mCRC: Key Takeaways From the Recently Presen…

2021 ASCO Virtual Direct™ Highlights

A. Loaiza-Bonilla

28 views

ASCO 2021 Q&A Session on Key Clinical Data in Lung Cancers

2021 ASCO Virtual Direct™ Highlights

J. Bauman, R. Gentzler

17 views

ASCO 2021 Highlights on Metastatic Lung Cancers: IO Combos, Frequenc…

2021 ASCO Virtual Direct™ Highlights

R. Gentzler

22 views

ASCO 2021 Q&A Discussion on GU Cancers: Clinical Data Overview From …

2021 ASCO Virtual Direct™ Highlights

V. Narayan, P. Ghatalia

112 views

2021 ASCO Key Takeaways From Non-prostate Cancer Studies: Adjuvant T…

2021 ASCO Virtual Direct™ Highlights

P. Ghatalia

24 views

2021 ASCO Highlights on mPC: “Doublet” vs. “Triplet" Therapy in mCSP…

2021 ASCO Virtual Direct™ Highlights

V. Narayan

19 views

2021 ASCO Lymphoma and Leukemia Q&A Session: Impact of Recent Trial …

2021 ASCO Virtual Direct™ Highlights

J. Svoboda, R. Redner

21 views

ASCO 2021 Q&A Session on the Practice-Changing Updates for BC

2021 ASCO Virtual Direct™ Highlights

E. Lower, C. Ma

23 views

2021 ASCO Updates on MBC: Dalpiciclib + Fulvestrant, ET +/- CDK4/6i…

2021 ASCO Virtual Direct™ Highlights

E. Lower

11 views

Total Health Conferencing

2021 ASCO Virtual Direct™ Highlights Philadelphia

Sat, Jul 24, 2021

Login

Login

Join VuMedi

2021 ASCO Virtual Direct™ Highlights

2021 ASCO Key Takeaways From Non-prostate Cancer Studies: Adjuvant Therapy for RCC, 1L Therapy for mRCC, IO/TKI in nccRCC

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

ASCO 2021 Q&A Discussion on GI Cancers: New Findings and Data Overvi…

2021 ASCO Highlights on mCRC: Key Takeaways From the Recently Presen…

ASCO 2021 Q&A Session on Key Clinical Data in Lung Cancers

ASCO 2021 Highlights on Metastatic Lung Cancers: IO Combos, Frequenc…

ASCO 2021 Q&A Discussion on GU Cancers: Clinical Data Overview From …

2021 ASCO Key Takeaways From Non-prostate Cancer Studies: Adjuvant T…

2021 ASCO Highlights on mPC: “Doublet” vs. “Triplet" Therapy in mCSP…

2021 ASCO Lymphoma and Leukemia Q&A Session: Impact of Recent Trial …

ASCO 2021 Q&A Session on the Practice-Changing Updates for BC

2021 ASCO Updates on MBC: Dalpiciclib + Fulvestrant, ET +/- CDK4/6i​…

2021 ASCO Virtual Direct™ Highlights Philadelphia

2021 ASCO Updates on MBC: Dalpiciclib + Fulvestrant, ET +/- CDK4/6i…